1. Home
  2. BORR vs AMLX Comparison

BORR vs AMLX Comparison

Compare BORR & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

HOLD

Current Price

$4.43

Market Cap

1.9B

Sector

Energy

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$15.40

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BORR
AMLX
Founded
2016
2014
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
BORR
AMLX
Price
$4.43
$15.40
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
$6.25
$21.56
AVG Volume (30 Days)
10.1M
1.2M
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.46
EPS
N/A
N/A
Revenue
N/A
$380,786,000.00
Revenue This Year
$5.80
N/A
Revenue Next Year
$21.67
N/A
P/E Ratio
$20.64
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$1.81
$4.86
52 Week High
$6.66
$18.61

Technical Indicators

Market Signals
Indicator
BORR
AMLX
Relative Strength Index (RSI) 30.70 59.48
Support Level $4.16 $12.17
Resistance Level $4.55 $15.37
Average True Range (ATR) 0.23 0.88
MACD -0.06 0.28
Stochastic Oscillator 5.88 79.48

Price Performance

Historical Comparison
BORR
AMLX

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: